Zobrazeno 1 - 10
of 537
pro vyhledávání: '"azole antifungals"'
Autor:
Massimo Giuseppe De Cesaris, Giovanni D'Orazio, Chiara Fanali, Alessandra Gentili, Salvatore Fanali
Publikováno v:
Journal of Chromatography Open, Vol 5, Iss , Pp 100126- (2024)
In this study, the enantiorecognition and separation performance of cellulose tris-3,5-dichlorophenylcarbamate (CDCPC) as the chiral selector for the enantioseparation of some chiral antifungal compounds was investigated. The CDCPC was bonded to 5 µ
Externí odkaz:
https://doaj.org/article/462ffdbe5e424153baef0386583dd61b
Publikováno v:
Pharmacology Research & Perspectives, Vol 11, Iss 4, Pp n/a-n/a (2023)
Abstract Tacrolimus interacts with letermovir and azole antifungals, whereas letermovir has nonuniform effects on the pharmacokinetics of azole antifungals. We retrospectively investigated the interaction of tacrolimus (continuous infusion) with lete
Externí odkaz:
https://doaj.org/article/4597d5b9b3e840b7a38fba7af392f63f
Publikováno v:
Current Research in Toxicology, Vol 5, Iss , Pp 100119- (2023)
Azole antifungals, designed to inhibit fungal CYP51, have a liability to inhibit human CYP enzymes. Whilst drug-metabolizing CYPs are covered in preclinical safety assessment, those metabolizing endogenous bioactive molecules are usually not. Posacon
Externí odkaz:
https://doaj.org/article/f409fb4d1f5541d4862aba9eb1a7bcd3
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 71, Iss 3, Pp 1089-93 (2021)
Objective: To assess the correlation between biofilm formation and azole antifungal susceptibility against plank tonic and sessile clinical isolates of C.albicans. Study Design: Prospective observational study. Place and Duration of Study: Comb
Externí odkaz:
https://doaj.org/article/d04cfba7b49e4f6fb8527784df5e8d93
Publikováno v:
Antibiotics, Vol 12, Iss 5, p 884 (2023)
The use of antifungal drugs started in the 1950s with polyenes nystatin, natamycin and amphotericin B-deoxycholate (AmB). Until the present day, AmB has been considered to be a hallmark in the treatment of invasive systemic fungal infections. Neverth
Externí odkaz:
https://doaj.org/article/327f078ef6f34394ab765c4a55a98991
Publikováno v:
Indian Dermatology Online Journal, Vol 12, Iss 1, Pp 123-127 (2021)
Introduction: Cutaneous leishmaniasis (CL) is a vector-borne protozoal infection of the skin with variable clinical manifestations. In Rajasthan, western Thar desert is endemic for this disease. Aim: The present study was aimed to describe clinico-ep
Externí odkaz:
https://doaj.org/article/517aee200ce64c55aba331efbe58be10
Autor:
Tahereh Alikhani, Roshanak Daie Ghazvini, Mehdi Mirzaii, Seyed Jamal Hashemi, Mozhgan Fazli, Zahra Rafat, Davoud Roostaei, Pegah Ardi, Hasti Kamali Sarvestani, Mahdi Zareei
Publikováno v:
Iranian Journal of Public Health, Vol 51, Iss 4 (2022)
Background: Candida species are normal vaginal flora in healthy women, which can cause vulvovaginal candidiasis (VVC). The formation of biofilm is a cause of drug resistance in Candida species of vaginal origin. We aimed to specify Candida species ca
Externí odkaz:
https://doaj.org/article/57a055c6c038428781cadde2e5a09821
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marcia S. C. Melhem, Vivian C. Coelho, Claudia A. Fonseca, Lidiane de Oliveira, Lucas X. Bonfietti, Maria. W. Szeszs, Marcello M. C. Magri, Francine S. Dorneles, Hideaki Taguchi, Daniel V. S. Moreira, Adriana L. Motta, Marjorie V. Batista, Katsuhiko Kamei, Maria A. Shikanai-Yasuda
Publikováno v:
Pharmaceutics, Vol 14, Iss 10, p 2161 (2022)
Aspergillosis is an invasive fungal disease associated with high mortality. Antifungal susceptibility testing (AFST) is receiving increasing consideration for managing patients, as well as for surveilling emerging drug resistance, despite having time
Externí odkaz:
https://doaj.org/article/b16a7b5961b44a3e80b76ca3aa0be3a5
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Current drug regimens for cutaneous leishmaniasis (CL) include toxic systemic therapies such as amphotericin B (AB) and pentavalent antimonials. Fluconazole (FZ) is a well-tolerated potential oral alternative for the management CL
Externí odkaz:
https://doaj.org/article/93f68d6766db4dfcb2725204077f15a5